During the three year performance period of the Special Investment Facilitation Council (SIFC), several important initiatives were undertaken in the health sector, contributing to the improvement and development of the healthcare system.
The federal cabinet approved the National Vaccine Policy, paving the way for vaccine manufacturing in the country and production in line with international standards.
Under the National Blood Transfusion Policy, the system for blood safety and plasma production was further strengthened, while reduced prices of commonly used medicines improved the availability of medicines in the market.
A project to establish Pakistan as a medical tourism hub was also launched to attract patients from abroad for treatment. The Central Drug Testing Laboratory of DRAP received approval from the World Health Organization (WHO), increasing global confidence in Pakistani medicines. New opportunities were also created in health technology, telemedicine, and foreign investment.
With the support of SIFC, the 30th Annual International Conference of the Pakistan Association of Plastic Surgeons was organized. Meanwhile, in 2025, the health sector’s profit reached a record level of Rs42.2 billion, reflecting an increase of 78 percent.
